Profile picture for user agénor.madina

Madina Agénor

Gerald Gill Assistant Professor of Community Health, Tufts University
Chapter Member: Boston SSN
Areas of Expertise:
  • Health Care
  • Reproductive Health

Connect with Madina

About Madina

Agénor is a social epidemiologist and health services researcher who uses quantitative and qualitative research methods to investigate intersectional inequities in sexual and reproductive health and cancer screening and prevention in relation to sexual orientation, gender identity, and race/ethnicity. Specifically, Agénor’s research examines the social and policy determinants of cervical cancer screening, human papillomavirus (HPV) vaccination, sexually transmitted infection (STI) risk, prevention, and testing, and reproductive health and rights among socially and economically marginalized populations, especially women and girls of color, sexual minority women, and transgender and non-binary individuals.

Contributions | No Jargon Podcast | In the News | Publications

Contributions

Why Policies Meant to Discourage Poor Women from Having Children are Ineffective and Punitive

    Diana Romero
SSN Key Findings Brief,

No Jargon Podcast

In the News

"Separate and Unequal," Madina Agénor (with Jessica Arons), Center for American Progress, December 6, 2010.

Publications

"Sexual Orientation Disparities in the Utilization of Sexual Health Services in a National Probability Sample of U.S. Women" (with Christina Muzny, Vanessa Schick, Erika L. Austin, and Jennifer Potter). Preventive Medicine 95 (2017): 74-81.

Uses multivariable logistic regression to examine the associations between sexual behavior and sexual identity (modeled separately) and sexually transmitted infections testing in the past year, Pap test use in the last three years, lifetime HIV testing, and lifetime human papillomavirus (HPV) testing. 

"Gender Identity Disparities in Pap Test Use in a Sample of Binary and Non-Binary Transmasculine Adults" (with Jaclyn M. White Hughto, Sarah M. Peitzmeier, Jennifer Potter, Madeline B. Deutsch, Dana J. Pardee, and Sari L. Reisner). Journal of General Internal Medicine 33, no. 7 (2018): 1015–1017.

Examines whether cervical cancer screening differs between individuals assigned female at birth who self-identify as men, transgender men, or FTM (i.e. binary) and those who self-identify as another transmasculine gender identity such as neither exclusively male nor female, agender, or genderqueer (i.e. non-binary).

"Perceptions of Cervical Cancer Risk and Screening among Transmasculine Individuals: Patient and Provider Perspectives" (with Sarah Peitzmeier, Ida Bernstein, and Jennifer Potter). Culture, Health & Sexuality 18, no. 10 (2016): 1192-1206.

Examines transmasculine individuals' and healthcare providers' perceptions of cervical cancer risk and screening among individuals on the transmasculine continuum.

"Sexual Orientation and Sexual and Reproductive Health among African American Sexual Minority Women in the U.S. South" (with S. Bryn Austin, Daniel Kort, Erika L. Austin, and Christina Muzny). Women's Health Issues 26, no. 6 (2016): 612-621.

Finds that several sexual and reproductive health indicators vary in relation to sexual identity and sexual behavior among Southern African American sexual minority women. Interventions that facilitate access to sexual and reproductive health services and are tailored to the unique needs of sexual orientation subgroups of sexual minority women are needed.

"Sexual Orientation Identity Disparities in Awareness and Initiation of the Human Papillomavirus Vaccine among U.S. Women and Girls: A National Survey" (with Sarah M. Peitzmeier, Allegra R. Gordon, Sebastien J.P.A. Haneuse, Jennifer E. Potter, and S. Bryn Austin). Annals of Internal Medicine 163, no. 2 (2015): 99-106.

Examines the association between sexual orientation identity and HPV vaccination among U.S. women and girls.